quadrivalent flu vaccine
Selected indexed studies
- Influenza vaccination: protecting the most vulnerable. (Eur Respir Rev, 2021) [PMID:33650528]
- A phase 3 randomized safety and immunogenicity trial of mRNA-1010 seasonal influenza vaccine in adults. (Vaccine, 2025) [PMID:39919447]
- [Seasonal flu vaccination for older people: Evaluation of the quadrivalent vaccine. Positioning report]. (Rev Esp Geriatr Gerontol, 2018) [PMID:30107941]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Quadrivalent inactivated influenza vaccine (VaxigripTetra™). (2018) pubmed
- Fluarix quadrivalent vaccine for influenza. (2015) pubmed
- A phase 3 randomized safety and immunogenicity trial of mRNA-1010 seasonal influenza vaccine in adults. (2025) pubmed
- Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial. (2021) pubmed
- Influenza vaccination: protecting the most vulnerable. (2021) pubmed
- [Seasonal flu vaccination for older people: Evaluation of the quadrivalent vaccine. Positioning report]. (2018) pubmed
- Quadrivalent influenza nanoparticle vaccines induce broad protection. (2021) pubmed
- [Influenza]. (2021) pubmed
- Quadrivalent Live-Attenuated Influenza Vaccine in Milan preschools: an Italian experience of school-located flu vaccination within the 2022-2023 season. (2024) pubmed
- Lupus and vaccinations. (2018) pubmed